BioCentury
ARTICLE | Company News

AM-Pharma, Pfizer deal

May 18, 2015 7:00 AM UTC

Pfizer purchased a 17.5% equity stake in AM-Pharma and received an option acquire the remainder of the company. The option is exercisable upon completion of a Phase II trial of AM-Pharma’s recAP recom...